Alprostadil Liposomes for Injection for Lower Extremity Arteriosclerosis Obliteran
Clinical trial NCT04197323 · UNKNOWN
Trial details
- NCT number
- NCT04197323
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-01
- Primary completion
- 2021-06-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.